Lower Risk of One-Year Non-Relapse Mortality, Rapid Engraftment and Better NK Cell Recovery with GvHD Prophylaxis Based in Post-Transplant Cyclophosphamide/Bendamustine in Pediatric Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Ramirez, Oscar [1 ]
Portilla, Carlos Andres [1 ]
Buitrago, Jorge Luis [1 ]
Lopez, Eduardo [2 ]
机构：
[1] Ctr Med Imbanaco, Pediat Bone Marrow Transplantant Unit, Cali, Colombia
[2] Ctr Med Imbanaco, Pediat Infect Dis Dept, Cali, Colombia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
352
引用
收藏
页数：2
相关论文
共 50 条
  • [1] GVHD PROPHYLAXIS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Storti, G.
    Santoro, L.
    Marano, L.
    De Santis, G.
    Manfra, I.
    Urciuoli, E.
    Marotta, S.
    Frieri, C.
    Cacace, F.
    Pagliuca, S.
    Serio, B.
    D'Addona, M.
    Giudice, V.
    Guariglia, R.
    Palmieri, F.
    Selleri, C.
    Cantore, N.
    Risitano, A. M.
    HAEMATOLOGICA, 2021, 106 (10) : 179 - 180
  • [2] Post-transplant cyclophosphamide combined with ATG for GVHD prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
    Pasic, Ivan
    Lipton, Jeffrey
    Kim, Dennis
    Viswabandya, Auro
    Thyagu, Santhosh
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2019, 54 : 301 - 302
  • [3] HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
    Shike, Hiroko
    Zhang, Aiwen
    CELLS, 2024, 13 (24)
  • [4] Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease
    Harada, Kaito
    Kanda, Junya
    Hirayama, Masahiro
    Wada, Fumiya
    Uchida, Naoyuki
    Nakamae, Hirohisa
    Tanaka, Masatsugu
    Onizuka, Makoto
    Ohigashi, Hiroyuki
    Nakano, Nobuaki
    Fukuda, Takahiro
    Ishiwata, Kazuya
    Maruyama, Yumiko
    Eto, Tetsuya
    Ishimaru, Fumihiko
    Atsuta, Yoshiko
    Nakasone, Hideki
    Tanaka, Takashi
    BLOOD, 2023, 142
  • [5] Immunosuppression Free at One-Year Post Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)
    Solh, Melhem M.
    Solomon, Scott R.
    Morris, Lawrence
    Bachier-Rodriguez, Lizamarie
    Holland, H. Kent
    Zhang, Xu
    Jackson, Katelin C.
    Bashey, Asad
    BLOOD, 2023, 142
  • [6] Similar Risk of Relapse and Survival with Post-Transplant Cyclophosphamide Compared to Standard Gvhd Prophylaxis after Allogeneic Hematopoietic Cell Transplantation for AML and MDS
    Yasin, Hassaan
    Naqvi, Mahrukh
    Kim, Jongphil
    Faramand, Rawan
    Puglianini, Omar Alexis Castaneda
    Khimani, Farhad
    Lazaryan, Aleksandr
    Nishihori, Taiga
    Nieder, Michael
    Pidala, Joseph
    Bejanyan, Nelli
    BLOOD, 2022, 140 : 4886 - 4888
  • [7] Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Von Dem Borne, Peter A.
    Kemps-Mols, Berit M.
    de Wreede, Liesbeth C.
    van Beek, Adriaan A.
    Snijders, Tjeerd J. F.
    van Lammeren, Danielle
    Tijmensen, Janneke
    Sijs-Szabo, Aniko
    Bogel, Theo L. Nering
    Oudshoorn, Mirjam A.
    Halkes, Constantijn J. M.
    van Balen, Peter
    Marijt, Erik W. A. F.
    Tjon, Jennifer M. L.
    Vermaat, Joost S. P.
    Veelken, Hendrik
    BLOOD, 2022, 140 : 4735 - 4736
  • [8] Post-Transplant Cyclophosphamide (PTCY) as GVHD Prophylaxis for Hematopoietic Stem Cell Transplantation From Matched-Related Sibling Donors
    Storti, Gabriella
    Santoro, Lidia
    Marano, Luana
    De Santis, Giovanna
    Manfra, Ilenia
    Urciuoli, Eleonora
    Marotta, Serena
    Frieri, Camilla
    Cacace, Fabiana
    Pagliuca, Simona
    Serio, Bianca
    D'Addona, Matteo
    Giudice, Valentina
    Guariglia, Roberto
    Palmieri, Fausto
    Selleri, Carmine
    Cantore, Nicola
    Risitano, Antonio Maria
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 211 - 212
  • [9] Post-transplant cyclophosphamide as a graft versus host prophylaxis in pediatric haploidentical hematopoietic stem cell transplantation - case series
    Wawrzyniak-Dzierzek, Elzbieta
    Gajek, Kornelia
    Gorczynska, Ewa
    Kalwak, Krzysztof
    Ussowicz, Marek
    BONE MARROW TRANSPLANTATION, 2018, 53 : 713 - 714
  • [10] Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center experience
    M. Berro
    M. Rivas
    J. Trucco
    I. Paganini
    I. Ravchina
    G. Kusminsky
    Bone Marrow Transplantation, 2021, 56 : 986 - 988
12345